DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Alcohol, Behavior, and Brain Imaging

Early Phase 1

Completed

Conditions: Alcohol Drinking
Binge Drinking
Drinking Behavior
Substance-Related Disorders
Ethanol
Physiological Effects of Drugs
Central Nervous System Depressants

Interventions: Other: Placebo
Drug: Ethanol

First Posted Date: 2019-04-29

Last Posted Date: 2022-04-25

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT03930446

Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy

Not Applicable

Recruiting

Conditions: Mechanical Ventilation Complication

Interventions: Other: Volume Support Mode Mechanical Ventilation
Other: Assist Control Mode Mechanical Ventilation

First Posted Date: 2019-04-03

Last Posted Date: 2024-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 468

Registration Number: NCT03901924

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States

Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

Phase 2

Recruiting

Conditions: Breast Cancer
Breast Cancer Female
HER2-positive Breast Cancer
Breast Cancer Stage II
Breast Cancer Stage III

Interventions: Drug: Docetaxel
Drug: Herceptin
Drug: FEC
Drug: LHRH agonist
Drug: Tamoxifen
Drug: Letrozole

First Posted Date: 2019-03-19

Last Posted Date: 2023-03-07

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT03879577

Locations: 🇳🇬
University College Hospital, Ibadan, Nigeria, Ibadan, Nigeria

Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

Not Applicable

Completed

Conditions: Peritoneal Mesothelioma
Mesothelioma

Interventions: Diagnostic Test: HR-MRI
Diagnostic Test: Standard CT Imaging
Diagnostic Test: Ultrasound

First Posted Date: 2019-03-08

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 26

Registration Number: NCT03867578

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

A Narrative Intervention to Decrease Abortion Stigma

Not Applicable

Completed

Conditions: Stigma, Social

Interventions: Behavioral: Narrative Intervention

First Posted Date: 2019-03-06

Last Posted Date: 2020-04-20

Lead Sponsor: University of Chicago

Target Recruit Count: 215

Registration Number: NCT03865199

Locations: 🇺🇸
Planned Parenthood, Chicago, Illinois, United States

Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia

Phase 1

Active, not recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Decitabine
Drug: Venetoclax

First Posted Date: 2019-02-18

Last Posted Date: 2024-11-11

Lead Sponsor: University of Chicago

Target Recruit Count: 26

Registration Number: NCT03844815

Locations: 🇺🇸
University Of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

At Home Spirometry and Video Module Education for COPD Patients

Not Applicable

Completed

Conditions: COPD

Interventions: Other: BREATHES Program
Device: BREATHES SpiroPD or Propeller Health

First Posted Date: 2019-02-07

Last Posted Date: 2022-07-22

Lead Sponsor: University of Chicago

Target Recruit Count: 71

Registration Number: NCT03834350

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

Patient Outcomes Reporting for Timely Assessments of Life With Depression: PORTAL-Depression

Not Applicable

Completed

Conditions: Depressive Disorder, Major
Depression

Interventions: Other: CAT-DI monitoring via MyChart
Diagnostic Test: CAD-MDD/CAT-DI screening via MyChart
Diagnostic Test: CAD-MDD/CAT-DI screening during clinic visit
Other: PHQ-9 monitoring during clinic visits

First Posted Date: 2019-02-06

Last Posted Date: 2021-04-30

Lead Sponsor: University of Chicago

Target Recruit Count: 4161

Registration Number: NCT03832283

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Differential Responses to Drugs and Sweet Tastes

Phase 1

Completed

Conditions: Bipolar II Disorder

Interventions: Drug: d-amphetamine 10 mg oral capsule
Drug: d-amphetamine 20 mg oral capsule
Drug: Placebo oral capsule

First Posted Date: 2019-01-22

Last Posted Date: 2023-02-22

Lead Sponsor: University of Chicago

Target Recruit Count: 93

Registration Number: NCT03810703

Locations: 🇺🇸
University of Chicago Medical Center - Human Behavioral Pharmacology Lab, Chicago, Illinois, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Individual Differences in Drug Response

Early Phase 1

Completed

Conditions: Differential Female Response to Δ9-tetrahydrocannabinol (THC)

Interventions: Drug: dextrose
Drug: Dronabinol

First Posted Date: 2019-01-18

Last Posted Date: 2024-07-03

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT03809546

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy